Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management

Unlike conventional Coronavirus 2019 (COVID-19) vaccines, intranasal vaccines display a superior advantage because the nasal mucosa is often the initial site of infection. Preclinical and clinical studies concerning intranasal immunization elicit high neutralizing antibody generation and mucosal IgA...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Drug Discov Today
Main Authors: Chavda, Vivek P., Vora, Lalitkumar K., Pandya, Anjali K., Patravale, Vandana B.
Format: Artigo
Sprog:Inglês
Udgivet: Elsevier Ltd. 2021
Fag:
Keynote (Green)
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8319039/
https://ncbi.nlm.nih.gov/pubmed/34332100
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drudis.2021.07.021
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker